Literature DB >> 6982681

Antibacterial activity and beta-lactamase stability of temocillin.

K Jules, H C Neu.   

Abstract

Temocillin, a 6-alpha-methoxy penicillin, inhibited 90% of strains of Escherichia coli, Klebsiella pneumoniae, Citrobacter, Proteus, Providencia, Salmonella, and Shigella at a concentration of less than or equal to 16 micrograms/ml. Haemophilus influenzae and Neisseria gonorrhoea were inhibited by less than or equal to 1 microgram/ml. Changing the medium or pH of the cultures did not alter the minimal inhibitory concentrations, which were similar in broth and human serum, as were the minimal bactericidal concentrations. An increase in inoculum size from 10(5) to 10(7) colony-forming units increased concentration required for inhibition. Temocillin inhibited strains resistant to ampicillin, ticarcillin, cefazolin, cefamandole, and cefoxitin. Most Pseudomonas aeruginosa strains and other Pseudomonas spp. and Acinetobacter spp. were resistant, as were gram-positive organisms. Temocillin was not hydrolyzed by the common plasmid and chromosomal beta-lactamases but inhibited them. The resistance of certain gram-negative bacilli to temocillin seemed to be a result of failure of the molecule to enter through the cell wall, since combination of temocillin with EDTA made Pseudomonas, Acinetobacter, and Enterobacter strains susceptible to low concentrations of the compound.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982681      PMCID: PMC183765          DOI: 10.1128/AAC.22.3.453

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Antagonism of the antibacterial action of some penicillins by other penicillins and cephalosporins.

Authors:  J F Acar; L D Sabath; P A Ruch
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

Review 2.  Plasmid-mediated beta-lactamases of Gram-negative bacteria: properties and distribution.

Authors:  M Matthew
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

3.  Substituted penicillin and cephalosporin derivatives. I. Stereospecific introduction of the C-6(7) methoxy group.

Authors:  L D Cama; W J Leanza; T R Beattie; B G Christensen
Journal:  J Am Chem Soc       Date:  1972-02-23       Impact factor: 15.419

Review 4.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

5.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

6.  The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.

Authors:  K P Fu; H C Neu
Journal:  J Antibiot (Tokyo)       Date:  1979-09       Impact factor: 2.649

7.  Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

8.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  Dissociated resistance among cephalosporins.

Authors:  P M Waterworth; A M Emmerson
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

10.  Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity.

Authors:  N H Georgopapadakou; F Y Liu
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

View more
  30 in total

Review 1.  The penicillins today.

Authors:  R Finch
Journal:  BMJ       Date:  1990-05-19

2.  Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States.

Authors:  Elise T Zeiser; Scott A Becka; Melissa D Barnes; Magdalena A Taracila; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

Review 3.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

4.  Influence of temocillin on human bowel flora.

Authors:  H W Mittermayer
Journal:  Drugs       Date:  1985       Impact factor: 9.546

5.  A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.

Authors:  J Focht; H D Heilmann; S Heinrich; W Klietmann
Journal:  Drugs       Date:  1985       Impact factor: 9.546

6.  Antibacterial activity of temocillin in combination with other beta-lactam antibiotics.

Authors:  L Verbist; J Verhaegen
Journal:  Drugs       Date:  1985       Impact factor: 9.546

7.  What do beta-lactamases mean for clinical efficacy?

Authors:  H C Neu
Journal:  Infection       Date:  1983       Impact factor: 3.553

8.  Effect of temocillin in combination with other beta-lactam antibiotics.

Authors:  L Verbist; J Verhaegen
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

9.  Substituted aryl malonamates as new serine beta-lactamase substrates: structure-activity studies.

Authors:  S A Adediran; D Cabaret; J-F Lohier; M Wakselman; R F Pratt
Journal:  Bioorg Med Chem       Date:  2009-10-31       Impact factor: 3.641

Review 10.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.